<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD10210000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P52895</UniProt_ID>
  <Seq_Length>323</Seq_Length>
  <Molecule_Weight>36735</Molecule_Weight>
  <KEGG_ID>hsa:1646</KEGG_ID>
  <Orthology_ID>K00089</Orthology_ID>
  <Function_Summary>Works in concert with the 5-alpha/5-beta-steroid reductases to convert steroid hormones into the 3-alpha/5-alpha and 3-alpha/5-beta-tetrahydrosteroids. Catalyzes the inactivation of the most potent androgen 5-alpha-dihydrotestosterone (5-alpha-DHT) to 5-alpha-androstane-3-alpha,17-beta-diol (3-alpha-diol). Has a high bile-binding ability.</Function_Summary>
  <Catalytic_Mechanism>Trans-1,2-dihydrobenzene-1,2-diol + NADP(+) = catechol + NADPH.@@A 3-alpha-hydroxysteroid + NAD(P)(+) = a 3-oxosteroid + NAD(P)H.</Catalytic_Mechanism>
  <Pfam_ID>PF00248:Aldo_ket_red</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>5</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Dihydrodiol dehydrogenase 2</Alias>
      <Alias>3-alpha-HSD3</Alias>
      <Alias>DD/BABP</Alias>
      <Alias>DD2</Alias>
      <Alias>Dihydrodiol dehydrogenase/bile acid-binding protein</Alias>
      <Alias>Chlordecone reductase homolog HAKRD</Alias>
      <Alias>DD-2</Alias>
      <Alias>Type III 3-alpha-hydroxysteroid dehydrogenase</Alias>
      <Alias>Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase</Alias>
      <Alias>1.3.1.20&lt;/ecNumber</Alias>
      <Alias>1.1.1.213&lt;/ecNumber</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the reaction: NADP+ + trans-1,2-dihydrobenzene-1,2-diol = NADPH + catechol.</Detail>
      <Keyword>Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity</Keyword>
      <Ontology_ID>GO:0047115</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Combining with prostaglandin F (PGF (2-alpha)) to initiate a change in cell activity.</Detail>
      <Keyword>Prostaglandin F receptor activity</Keyword>
      <Ontology_ID>GO:0004958</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: phenanthrene + O2 + NADH + H+ = H2O + NAD+ + phenanthrene-9,10-oxide.</Detail>
      <Keyword>Phenanthrene 9,10-monooxygenase activity</Keyword>
      <Ontology_ID>GO:0018636</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: NAD(P)+ + androsterone = NAD(P)H + H+ + 5-alpha-androstane-3,17-dione. The reaction is A-specific (i.e. the pro-R hydrogen is transferred from the 4-position of reduced nicotinamide cofactor) with respect to NAD(P)+.</Detail>
      <Keyword>Androsterone dehydrogenase (A-specific) activity</Keyword>
      <Ontology_ID>GO:0047026</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: an alditol + NADP+ = an aldose + NADPH + H+.</Detail>
      <Keyword>Aldehyde reductase activity</Keyword>
      <Ontology_ID>GO:0004032</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: O2 + NADPH + progesterone = H2O + NADP+ + testosterone acetate.</Detail>
      <Keyword>Ketosteroid monooxygenase activity</Keyword>
      <Ontology_ID>GO:0047086</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with bile acids, any of a group of steroid carboxylic acids occurring in bile.</Detail>
      <Keyword>Bile acid binding</Keyword>
      <Ontology_ID>GO:0032052</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of an oxidation-reduction (redox) reaction in which NADH or NADPH acts as a hydrogen or electron donor and reduces a quinone or a similar acceptor molecule.</Detail>
      <Keyword>Oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor</Keyword>
      <Ontology_ID>GO:0016655</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>300</Position>
      <Original>Asn</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>222</Position>
      <Original>His</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>90</Position>
      <Original>His</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>172</Position>
      <Original>Leu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>46</Position>
      <Original>Phe</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>79</Position>
      <Original>Ile</Original>
      <Variation>Val</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving steroids, compounds with a 1,2,cyclopentanoperhydrophenanthrene nucleus.</Detail>
      <Keyword>Steroid metabolic process</Keyword>
      <Ontology_ID>GO:0008202</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving prostaglandins, any of a group of biologically active metabolites which contain a cyclopentane ring due to the formation of a bond between two carbons of a fatty acid. They have a wide range of biological activities.</Detail>
      <Keyword>Prostaglandin metabolic process</Keyword>
      <Ontology_ID>GO:0006693</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons.</Detail>
      <Keyword>Oxidation-reduction process</Keyword>
      <Ontology_ID>GO:0055114</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The whole of the physical, chemical, and biochemical processes carried out by multicellular organisms to break down ingested nutrients into components that may be easily absorbed and directed into metabolism.</Detail>
      <Keyword>Digestion</Keyword>
      <Ontology_ID>GO:0007586</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving progesterone, a steroid hormone produced in the ovary which prepares and maintains the uterus for pregnancy. Also found in plants.</Detail>
      <Keyword>Progesterone metabolic process</Keyword>
      <Ontology_ID>GO:0042448</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostagladin stimulus.</Detail>
      <Keyword>Response to prostaglandin stimulus</Keyword>
      <Ontology_ID>GO:0034694</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the rate or extent of cell proliferation.</Detail>
      <Keyword>Positive regulation of cell proliferation</Keyword>
      <Ontology_ID>GO:0008284</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a jasmonic acid stimulus.</Detail>
      <Keyword>Cellular response to jasmonic acid stimulus</Keyword>
      <Ontology_ID>GO:0071395</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. Includes fatty acids; neutral fats, other fatty-acid esters, and soaps; long-chain (fatty) alcohols and waxes; sphingoids and other long-chain bases; glycolipids, phospholipids and sphingolipids; and carotenes, polyprenols, sterols, terpenes and other isoprenoids.</Detail>
      <Keyword>Lipid metabolic process</Keyword>
      <Ontology_ID>GO:0006629</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the protein kinase B signaling cascade, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.</Detail>
      <Keyword>Positive regulation of protein kinase B signaling cascade</Keyword>
      <Ontology_ID>GO:0051897</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>MDSKYQCVKLNDGHFMPVLGFGTYAPAEVPKSKALEAVKLAIEAGFHHIDSAHVYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSNSHRPELVRPALERSLKNLQLDYVDLYLIHFPVSVKPGEEVIPKDENGKILFDTVDLCATWEAMEKCKDAGLAKSIGVSNFNHRLLEMILNKPGLKYKPVCNQVECHPYFNQRKLLDFCKSKDIVLVAYSALGSHREEPWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTSEEMKAIDGLNRNVRYLTLDIFAGPPNYPFSDEY</Protein_Seq>
    <DNA_Seq>GTAAGAAACGGTTGAACTGGATGCAATTTTTATCACAGCTTGTGTAAGACTGCCTCTGTCCCTCCTCTCACATGCCATTGGTTAACCAGCAGACAGTGTGCTCAGGGGCGTTGCCAGCTCATTGCTCTTATAGCCTGTGAGGGAGGAAGAAACATTTGCTAACCAGGCCAGTGACAGAAATGGATTCGAAATACCAGTGTGTGAAGCTGAATGATGGTCACTTCATGCCTGTCCTGGGATTTGGCACCTATGCGCCTGCAGAGGTTCCTAAAAGTAAAGCTCTAGAGGCCGTCAAATTGGCAATAGAAGCCGGGTTCCACCATATTGATTCTGCACATGTTTACAATAATGAGGAGCAGGTTGGACTGGCCATCCGAAGCAAGATTGCAGATGGCAGTGTGAAGAGAGAAGACATATTCTACACTTCAAAGCTTTGGAGCAATTCCCATCGACCAGAGTTGGTCCGACCAGCCTTGGAAAGGTCACTGAAAAATCTTCAATTGGACTATGTTGACCTCTATCTTATTCATTTTCCAGTGTCTGTAAAGGAGGACATAGGGATTTTAACATGGAAGAAGAGCCCTAAACATAACTCCTAATTCCTTTCTATGGAACAGAAAGCAATTTTGAATCCATACTTCCGTGATTGCATGTCTACAAGAAAAGAGAGTGCAGAATCCTCAAAGCCTCTGCCTCAAAAACTTGAGGAAATGACAATCATCTCCTTGAAGGCACAAGGTCTTATTTATGATTCCTGATTTCACCTCTTGGGATGTTCACAGACACAGAGTTTCATGAAGCTGTGGTGTCCAGAAAACCTGCTGCACATAGGGTGCACAATGAGTTTCCATCTTCTTGCCTCTTTTCAAGGGGCAAGAACTCAGTCCGGGAATGTCTTAAACTACAAACCTTCATGGGAAACCTTGTTGCTTCTGCTTCCTCTCTTTTCACACTGGAGGTTTTATTTTTGCTTAGCCATGAATTCTTGTGTCATTCATAACTTTTGTCTTAAGGTACTGAAAACTAGTCAGGCTAGTTAATGCAAAAGGGTATATTAGATATGATAATGGGAAATCAAAGCCAGGGCTACATTAAGAA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Fetal testes</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
      <Ontology_ID>GO:0005737</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>AKR1C2</Gene_Name>
    <Gene_Alias>DDH2</Gene_Alias>
    <Gene_ID>1646</Gene_ID>
    <Genbank_ACCN>NM_001135241</Genbank_ACCN>
    <Protein_ACCN>NP_001128713</Protein_ACCN>
    <HGNC_ID>385</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/1646</Gene_URL>
    <UCSC_ID>uc001ihs.3</UCSC_ID>
    <EMBL_ID>ENSG00000265231</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Obesity, Hyperphagia, and Developmental Delay</Disease_Name>
      <Disease_Detail>Obesity</Disease_Detail>
      <Disease_DB>OBS015</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/obesity_hyperphagia_and_developmental_delay?search=AKR1C2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Liver Cancer</Disease_Name>
      <Disease_Detail>Liver Cancer</Disease_Detail>
      <Disease_DB>LVR011</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/liver_cancer?search=AKR1C2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>46xy Sex Reversal 8, Modifier of</Disease_Name>
      <Disease_Detail>46xy Sex Reversal 8</Disease_Detail>
      <Disease_DB>46X022</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/46xy_sex_reversal_8_modifier_of?search=AKR1C2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>46xy Sex Reversal 8</Disease_Name>
      <Disease_Detail>46xy Sex Reversal 8</Disease_Detail>
      <Disease_DB>46X021</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/46xy_sex_reversal_8?search=AKR1C2#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Human 3alpha-HSD type 3 in Ternary Complex with NADP and Testosterone</PDB_Title>
      <PDB_ID>1J96</PDB_ID>
      <Resolution>1.25</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1J96</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of the human 3alpha-hydroxysteroid dehydrogenase type 3 in complex with testosterone and NADP at 1.25-A resolution.</PubMed_Title>
      <Author>Nahoum, V., et al.</Author>
      <Journal>J.Biol.Chem.(2001)276:42091-42098</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11514561?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Human Type III 3-alpha-Hydroxysteroid Dehydrogenase/Bile Acid Binding Protein (AKR1C2) Complexed with NADP+ and Ursodeoxycholate</PDB_Title>
      <PDB_ID>1IHI</PDB_ID>
      <Resolution>3.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1IHI</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of human type III 3alpha-hydroxysteroid dehydrogenase/bile acid binding protein complexed with NADP(+) and ursodeoxycholate.</PubMed_Title>
      <Author>Jin, Y., et al.</Author>
      <Journal>Biochemistry(2001)40:10161-10168</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11513593?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of h3alpha-hydroxysteroid dehydrogenase type 3 mutant Y24A in complex with NADP+ and epi-testosterone</PDB_Title>
      <PDB_ID>2IPJ</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2IPJ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Mouse 17alpha-Hydroxysteroid Dehydrogenase (AKR1C21) Binds Steroids Differently from other Aldo-keto Reductases: Identification and Characterization of Amino Acid Residues Critical for Substrate Binding.</PubMed_Title>
      <Author>Faucher, F., et al.</Author>
      <Journal>J.Mol.Biol.(2007)369:525-540</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17442338?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human type 3 3alpha-hydroxysteroid dehydrogenase in complex with NADP(H), citrate and acetate molecules</PDB_Title>
      <PDB_ID>1XJB</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1XJB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Comparison of crystal structures of human type 3 3alpha-hydroxysteroid dehydrogenase reveals an</PubMed_Title>
      <Author>Couture, J.-F., et al.</Author>
      <Journal>Protein Sci.(2005)14:1485-1497</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15929998?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human type 3 3alpha-hydroxysteroid dehydrogenase in complex with NADP(H)</PDB_Title>
      <PDB_ID>2HDJ</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2HDJ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal Structures of Mouse 17alpha-Hydroxysteroid Dehydrogenase (Apoenzyme and Enzyme-NADP(H) Binary Complex): Identification of Molecular Determinants Responsible for the Unique 17alpha-reductive Activity of this Enzyme.</PubMed_Title>
      <Author>Faucher, F., et al.</Author>
      <Journal>J.Mol.Biol.(2006)364:747-763</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17034817?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Fold>
    <SCOP_Class>Alpha and beta proteins (a/b)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.d.b.i.b.h.html</SCOP_URL>
    <CATH_Class>Class 3: Mixed Alpha-Beta </CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1ihi</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Reference>Jin Y, et al. Biochemistry. 2001 Aug 28;40(34):10161-8.</Site_Reference>
      <PubMed_ID>11513593</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>1.-.-.-</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC1/-/-/-.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD10210001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD10210002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD10210003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD10210004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD10218001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2013-04-23</Create_Date>
</Organism_Record>